M Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 19
Professionals
  • Investments
  • 104
  • Portfolio
  • 55
  • Exits
  • 17
Exits

M Ventures General Information

Description

Founded in 2009, M Ventures is the strategic, corporate venture capital arm of Merck KGaA and is based in Amsterdam, Netherlands. The firm also has offices in Darmstadt, Germany, Cambridge, Massachusetts and Yavne, Israel. The firm seeks to invest in healthcare, life sciences, performance materials, and other new businesses, in alignment with the strategic interests of Merck KGaA. The company provides early-stage and seed funding.

Contact Information

Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Accelerator/Incubator
Venture Capital
Primary Office
  • Gustav Mahlerplein 102
  • Toyo lto Building, 20th Floor
  • 1082 MA Amsterdam
  • Netherlands

M Ventures Investments (104)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
The Ferroelectric Memory Company 17-Nov-2020 Early Stage VC 0000 Application Specific Semiconductors Generating Revenue
000000 0000 07-Oct-2020 00000 00000 00000 Diagnostic Equipment Startup 000000 000000 00.0
0000 0000 25-Sep-2020 00000 00000 000.00 Food Products Generating Revenue
00000 16-Sep-2020 00000 00000 000.00 Other Semiconductors Generating Revenue 0000 000000 00.0
0000000000 03-Sep-2020 0000 00000 Drug Delivery Startup 000000 000000 00.0
000 000000 29-Jul-2020 00000 00000 0000 Biotechnology Generating Revenue
00000000 14-Jul-2020 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 1 0000 000000000 00.0
00000000 06-May-2020 00000 00000 000.00 Computers, Parts and Peripherals Generating Revenue
FoRx Therapeutics 22-Apr-2020 Seed Round 000.00 Drug Discovery Startup 0000000 0000000000000 00.0
Xilio Therapeutics 02-Mar-2020 Early Stage VC 00000 Biotechnology Pre-Clinical Trials
You’re viewing 10 of 104 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

M Ventures Exits (17)

Company Name Exit Date Exit Type Exit Size
F-star 22-Nov-2020 Reverse Merger
0000000 25-Oct-2019 000 00000
000000000 01-Jan-2019 000 00 00000000
000000000 000 28-Jun-2018 000 00000
00000000 01-Jun-2018 000 00 00000000
0000000 0000000000 16-Mar-2018 000000000000000000 00000
000000 26-Jan-2017 000 000.00
0000000 0000000000 01-Apr-2016 000000000000000000 00000
Raze Therapeutics 31-Dec-2015 Out of Business
Ambrx 17-Jun-2015 Buyout/LBO 00000
You’re viewing 10 of 17 exits. Get the full list »

M Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

M Ventures Team (74)

Name Title Deals Funds Boards Office
Javier Rodriguez Chief Financial Officer Darmstadt, Germany
Jasper Bos Ph.D Senior Vice President & Managing Director 00 0 0 Amsterdam, Netherlands
Christian Patze Ph.D Principal 0 Cambridge, MA
Sebastian Schoefer Ph.D Principal Darmstadt, Germany
Therese Liechtenstein Ph.D Principal 0 0 Amsterdam, Netherlands
You’re viewing 5 of 74 team members. Get the full list »